한글목차

고셰병의 동향과 예측

세계의 고셰병 시장은 2024-2030년의 CAGR이 2.1%로, 2030년까지 추정 20억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 유전자 이상의 유병률 증가, 고셰병과 관련 증상, 진단에 대한 소비자 의식의 향상, 치료 옵션의 용이한 가용성입니다. 세계의 고셰병 시장의 미래는 병원, 전문 클리닉, 홈케어 시장의 기회에 의해 유망시되고 있습니다.

고셰병 시장 인사이트

Lucintel의 예측에서는 1형이 중추신경계에 영향을 미치지 않고, 비신경질환이므로 예측 기간 중 가장 높은 성장이 전망됩니다.

병원이 최대 부문으로 유지될 것으로 생각됩니다.

아시아태평양은 의료비의 증가와 대기업의 존재에 의해 예측 기간 중 가장 높은 성장이 전망됩니다.

아래 11개의 주요 질문에 답변하고 있습니다. :

• Q.1.시장 부문 중 가장 유망하고 고성장인 기회는 무엇인가?
• Q.2.어느 부문이 보다 빠른 페이스로 성장하는가, 또 이유는?
• Q.3.향후 성장이 가속할 것으로 생각되는 지역과 이유는?
• Q.4.시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장에서 주요 과제와 비즈니스 리스크는?
• Q.5.이 시장에서 비즈니스 리스크와 경쟁의 위협은?
• Q.6.이 시장에서 새로운 동향과 이유는?
• Q.7.시장에서 고객의 수요 변화에는 어떤 것이 있는가?
• Q.8.이 시장에서 새로운 개발과 개발을 선도하고 있는 기업은?
• Q.9.이 시장의 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 구상을 진행시키고 있는가?
• Q.10.이 시장에서 경쟁 제품에는 어떤 것이 있으며, 재료 및 제품의 대체에 의한 시장 점유율 저하의 위협은 어느 정도 있는가?
• Q.11.과거 5년간 어떤 M&A가 시행되고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 고셰병 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년의 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 고셰병 시장 동향(2018-2023)과 예측(2024-2030)
• 질환의 유형별 세계의 고셰병 시장
  • 유형 1
  • 유형 2
  • 유형 3
  • 기타
• 진단별 세계의 고셰병 시장
  • 신체검사
  • 혈액검사
  • 영상 검사
  • 임신전 스크리닝과 출생전 검사
  • 기타
• 치료별 세계의 고셰병 시장
  • 수술
  • 약
  • 기타
• 최종 용도별 세계의 고셰병 시장
  • 병원
  • 전문 클리닉
  • 홈케어
  • 기타

제4장 2018-2030년의 지역별 시장 동향과 예측 분석

• 지역별 세계의 고셰병 시장
• 북미의 고셰병 시장
• 유럽의 고셰병 시장
• 아시아태평양 고셰병 시장
• 기타 지역의 고셰병 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 질환의 유형별 세계의 고셰병 시장의 성장 기회
  • 진단별 세계의 고셰병 시장의 성장 기회
  • 치료별 세계의 고셰병 시장의 성장 기회
  • 최종 용도별 세계의 고셰병 시장의 성장 기회
  • 지역별 세계의 고셰병 시장의 성장 기회
• 세계의 고셰병 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 고셰병 시장의 능력 확대
  • 세계의 고셰병 시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• ISU Abxis
• Johnson & Johnson
• Pfizer
• Protalix Biotherapeutics
• Sanofi S.A.
• Takeda Pharmaceutical

영문목차

Gaucher Disease Trends and Forecast

The future of the global gaucher disease market looks promising with opportunities in the hospital, specialty clinic, and homecare markets. The global gaucher disease market is expected to reach an estimated $2.0 billion by 2030 with a CAGR of 2.1% from 2024 to 2030. The major drivers for this market are the increasing prevalence of genetic abnormalities, growing consumer awareness towards the gaucher disease and its relevant symptoms, diagnosis, and the easy availability of the treatment options.

A more than 150-page report is developed to help in your business decisions.

Gaucher Disease by Segment

The study includes a forecast for the global gaucher disease by disease type, diagnosis, treatment, end use, and region.

Gaucher Disease Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Type 1
• Type 2
• Type 3
• Others

Gaucher Disease Market by Diagnosis [Shipment Analysis by Value from 2018 to 2030]:

• Physical Exam
• Blood Tests
• Imaging Tests
• Preconception Screening and Prenatal Testing
• Others

Gaucher Disease Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

• Surgery
• Medication
• Others

Gaucher Disease Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Specialty Clinics
• Homecare
• Others

Gaucher Disease Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Gaucher Disease Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gaucher disease companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gaucher disease companies profiled in this report include-

• Isu Abxis
• Johnson & Johnson
• Pfizer
• Protalix Biotherapeutics
• Sanofi S.A.
• Takeda Pharmaceutical

Gaucher Disease Market Insights

Lucintel forecasts that type 1 is expected to witness highest growth over the forecast period because it is condition does not affect the central nervous system "CNS" and becomes a non-neurological condition.

Hospitals will remain the largest segment.

APAC is expected to witness highest growth over the forecast period due to the increasing healthcare expenditure and presence of major players in this region.

Features of the Global Gaucher Disease Market

Market Size Estimates: Gaucher disease market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Gaucher disease market by various segments, such as by disease type, diagnosis, treatment, end use and region in terms of($B).

Regional Analysis: Gaucher disease market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease types, diagnosis, treatments, end uses, and region.s for the gaucher disease market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gaucher disease market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the gaucher disease market size?

Answer: The global gaucher disease market is expected to reach an estimated $2.0 billion by 2030.

Q.2. What is the growth forecast for gaucher disease market?

Answer: The global gaucher disease market is expected to grow with a CAGR of 2.1% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the gaucher disease market?

Answer: The major drivers for this market are the increasing prevalence of genetic abnormalities, growing consumer awareness towards the gaucher disease and its relevant symptoms, diagnosis, and the easy availability of the treatment options.

Q.4. What are the major segments for gaucher disease market?

Answer: The future of the gaucher disease market looks promising with opportunities in the hospital, specialty clinic, and homecare markets.

Q.5. Who are the key gaucher disease market companies?

Answer: Some of the key gaucher disease companies are as follows:

• ISU Abxis
• Johnson & Johnson
• Pfizer
• Protalix Biotherapeutics
• Sanofi S.A.
• Takeda Pharmaceutical

Q.6. Which gaucher disease market segment will be the largest in future?

Answer: Lucintel forecasts that type 1 is expected to witness highest growth over the forecast period because it is condition does not affect the central nervous system "CNS" and becomes a non-neurological condition.

Q.7. In gaucher disease market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to the increasing healthcare expenditure and presence of major players in this region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the gaucher disease market by disease type (type 1, type 2, type 3, and others), diagnosis (physical exam, blood tests, imaging tests, preconception screening and prenatal testing, and others), treatment (surgery, medication, and others), end use (hospitals, specialty clinics, homecare, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Gaucher Disease Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Gaucher Disease Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Gaucher Disease Market by Disease Type
  • 3.3.1: Type 1
  • 3.3.2: Type 2
  • 3.3.3: Type 3
  • 3.3.4: Others
• 3.4: Global Gaucher Disease Market by Diagnosis
  • 3.4.1: Physical Exam
  • 3.4.2: Blood Tests
  • 3.4.3: Imaging Tests
  • 3.4.4: Preconception Screening and Prenatal Testing
  • 3.4.5: Others
• 3.5: Global Gaucher Disease Market by Treatment
  • 3.5.1: Surgery
  • 3.5.2: Medication
  • 3.5.3: Others
• 3.6: Global Gaucher Disease Market by End Use
  • 3.6.1: Hospitals
  • 3.6.2: Specialty Clinics
  • 3.6.3: Homecare
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Gaucher Disease Market by Region
• 4.2: North American Gaucher Disease Market
  • 4.2.2: North American Gaucher Disease Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
• 4.3: European Gaucher Disease Market
  • 4.3.1: European Gaucher Disease Market by Disease Type: Type 1, Type 2, Type 3, and Others
  • 4.3.2: European Gaucher Disease Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
• 4.4: APAC Gaucher Disease Market
  • 4.4.1: APAC Gaucher Disease Market by by Disease Type: Type 1, Type 2, Type 3, and Others
  • 4.4.2: APAC Gaucher Disease Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others
• 4.5: ROW Gaucher Disease Market
  • 4.5.1: ROW Gaucher Disease Market by by Disease Type: Type 1, Type 2, Type 3, and Others
  • 4.5.2: ROW Gaucher Disease Market by End Use: Hospitals, Specialty Clinics, Homecare, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Gaucher Disease Market by Disease Type
  • 6.1.2: Growth Opportunities for the Global Gaucher Disease Market by Diagnosis
  • 6.1.3: Growth Opportunities for the Global Gaucher Disease Market by Treatment
  • 6.1.4: Growth Opportunities for the Global Gaucher Disease Market by End Use
  • 6.1.5: Growth Opportunities for the Global Gaucher Disease Market by Region
• 6.2: Emerging Trends in the Global Gaucher Disease Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Gaucher Disease Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Gaucher Disease Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: ISU Abxis
• 7.2: Johnson & Johnson
• 7.3: Pfizer
• 7.4: Protalix Biotherapeutics
• 7.5: Sanofi S.A.
• 7.6: Takeda Pharmaceutical